Neal Edward Ready, MD, PhD

Professor of Medicine
Member of the Duke Cancer Institute
Campus mail 25178 Morris Bldg-200 Trent Dr., Box 3198, Durham, NC 27710
Phone (919) 681-6932
Email address neal.ready@duke.edu
In Their Words

Education and Training

  • Fellow in Hematology-Oncology, Medicine, Tufts University, 1992 - 1994
  • Fellow in Hematology-Oncology, Medicine, Brown University, 1990 - 1992
  • Medical Resident, Medicine, Brown University, 1986 - 1989
  • M.D., Vanderbilt University, 1986
  • Ph.D., University of California at Irvine, 1983

Publications

Khoury, T, Jang, D, Carrau, R, Ready, N, Barak, I, and Hachem, RA. "Role of induction chemotherapy in sinonasal malignancies: a systematic review." International Forum of Allergy & Rhinology 9, no. 2 (February 2019): 212-219. (Review)

PMID
30411867
Full Text

Ready, N, Farago, AF, de Braud, F, Atmaca, A, Hellmann, MD, Schneider, JG, Spigel, DR, Moreno, V, Chau, I, Hann, CL, Eder, JP, Steele, NL, Pieters, A, Fairchild, J, and Antonia, SJ. "Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032." Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 14, no. 2 (February 2019): 237-244.

PMID
30316010
Full Text

Zandberg, DP, Algazi, AP, Jimeno, A, Good, JS, Fayette, J, Bouganim, N, Ready, NE, Clement, PM, Even, C, Jang, RW, Wong, S, Keilholz, U, Gilbert, J, Fenton, M, Braña, I, Henry, S, Remenar, E, Papai, Z, Siu, LL, Jarkowski, A, Armstrong, JM, Asubonteng, K, Fan, J, Melillo, G, and Mesía, R. "Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy." European Journal of Cancer (Oxford, England : 1990) 107 (January 2019): 142-152.

PMID
30576970
Full Text

Liu, SV, Camidge, DR, Gettinger, SN, Giaccone, G, Heist, RS, Hodi, FS, Ready, NE, Zhang, W, Wallin, J, Funke, R, Waterkamp, D, Foster, P, Iizuka, K, and Powderly, J. "Long-term survival follow-up of atezolizumab in combination with platinum-based doublet chemotherapy in patients with advanced non-small-cell lung cancer." European Journal of Cancer (Oxford, England : 1990) 101 (September 2018): 114-122.

PMID
30053670
Full Text

Vokes, EE, Ready, N, Felip, E, Horn, L, Burgio, MA, Antonia, SJ, Arén Frontera, O, Gettinger, S, Holgado, E, Spigel, D, Waterhouse, D, Domine, M, Garassino, M, Chow, LQM, Blumenschein, G, Barlesi, F, Coudert, B, Gainor, J, Arrieta, O, Brahmer, J, Butts, C, Steins, M, Geese, WJ, Li, A, Healey, D, and Crinò, L. "Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases." Annals of Oncology : Official Journal of the European Society for Medical Oncology 29, no. 4 (April 2018): 959-965.

PMID
29408986
Full Text

Yang, C-FJ, McSherry, F, Mayne, NR, Wang, X, Berry, MF, Tong, B, Harpole, DH, D'Amico, TA, Christensen, JD, Ready, NE, and Klapper, JA. "Surgical Outcomes After Neoadjuvant Chemotherapy and Ipilimumab for Non-Small Cell Lung Cancer." The Annals of Thoracic Surgery 105, no. 3 (March 2018): 924-929.

PMID
29258674
Full Text

Yi, JS, Ready, N, Healy, P, Dumbauld, C, Osborne, R, Berry, M, Shoemaker, D, Clarke, J, Crawford, J, Tong, B, Harpole, D, D'Amico, TA, McSherry, F, Dunphy, F, McCall, SJ, Christensen, JD, Wang, X, and Weinhold, KJ. "Immune Activation in Early-Stage Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 23, no. 24 (December 2017): 7474-7482.

PMID
28951518
Full Text

Faries, MB, Mozzillo, N, Kashani-Sabet, M, Thompson, JF, Kelley, MC, DeConti, RC, Lee, JE, Huth, JF, Wagner, J, Dalgleish, A, Pertschuk, D, Nardo, C, Stern, S, Elashoff, R, Gammon, G, Morton, DL, and MMAIT-IV Clinical Trial Group, . "Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases." Annals of Surgical Oncology 24, no. 13 (December 2017): 3991-4000.

PMID
29019177
Full Text

Horn, L, Spigel, DR, Vokes, EE, Holgado, E, Ready, N, Steins, M, Poddubskaya, E, Borghaei, H, Felip, E, Paz-Ares, L, Pluzanski, A, Reckamp, KL, Burgio, MA, Kohlhäeufl, M, Waterhouse, D, Barlesi, F, Antonia, S, Arrieta, O, Fayette, J, Crinò, L, Rizvi, N, Reck, M, Hellmann, MD, Geese, WJ, Li, A, Blackwood-Chirchir, A, Healey, D, Brahmer, J, and Eberhardt, WEE. "Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 35, no. 35 (December 2017): 3924-3933.

PMID
29023213
Full Text

Stinchcombe, TE, Zhang, Y, Vokes, EE, Schiller, JH, Bradley, JD, Kelly, K, Curran, WJ, Schild, SE, Movsas, B, Clamon, G, Govindan, R, Blumenschein, GR, Socinski, MA, Ready, NE, Akerley, WL, Cohen, HJ, Pang, HH, and Wang, X. "Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 35, no. 25 (September 2017): 2885-2892.

PMID
28493811
Full Text

Pages